Bandaram Pharma board to meet Sept 30 to consider amalgamation

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Bandaram Pharma Packtech Limited scheduled a board meeting for September 30, 2026
  • The agenda includes considering a proposal for a scheme of arrangement or amalgamation
  • Trading window for company securities closed from September 27, 2026
  • Restriction remains until 48 hours after the outcome of the board meeting is declared
powered bylight_fuzz_icon
51982328

*this image is generated using AI for illustrative purposes only.

Bandaram Pharma Packtech Limited will convene a meeting of its Board of Directors on September 30, 2026. The primary agenda is to evaluate a proposal for a scheme of arrangement or amalgamation.

The company informed the BSE that the meeting will take place at its registered office in Bengaluru. In addition to the restructuring proposal, the Board may address other business matters with the permission of the Chair.

Trading window closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct, the trading window for securities has been closed effective September 27, 2026. This restriction applies to all connected persons, officers, designated employees, insiders, directors, and their immediate relatives.

The trading window will remain closed until 48 hours after the declaration of the outcome of the Board Meeting. This measure ensures that no insider trading occurs during the period when material non-public information regarding the potential corporate action is being deliberated.

Key details of the announcement

Detail Information
Company Bandaram Pharma Packtech Limited
Board Meeting Date September 30, 2026
Primary Agenda Scheme of Arrangement/Amalgamation
Trading Window Closed From September 27, 2026
Location Registered Office, Bengaluru

The company did not disclose specific financial figures, valuation metrics, or details regarding the entities involved in the proposed amalgamation in this initial intimation. Further details are expected to be released following the conclusion of the Board meeting and subsequent regulatory filings.

Historical Stock Returns for Bandaram Pharma Packtech

1 Day5 Days1 Month6 Months1 Year5 Years
+1.69%-1.40%+10.94%-25.52%-33.43%-10.25%

Which specific entities are involved in the proposed scheme of arrangement or amalgamation, and what are their relative market positions?

What is the expected timeline for regulatory approvals from SEBI and the National Company Law Tribunal following the Board's decision?

How might the proposed restructuring impact Bandaram Pharma Packtech's shareholding pattern and float requirements on the BSE?

Bandaram Pharma Packtech
View Company Insights
View All News
like16
dislike

Bandaram Pharma Packtech passes all five resolutions at FY26 AGM

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • All five resolutions passed unanimously at Bandaram Pharma's FY26 AGM
  • Total votes polled stood at 13,560,514 with zero votes against
  • Public shareholder voting participation remained low at approximately 34%
powered bylight_fuzz_icon
51793418

*this image is generated using AI for illustrative purposes only.

Bandaram Pharma Packtech Limited concluded its Annual General Meeting for FY26 on September 24, 2026, with all five proposed resolutions passed unanimously. The meeting, held via video conference, saw a total of 37 members participate electronically.

The agenda included the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. Members also approved the reappointment of Mr. Bhandaram Premasai Reddy as a director retiring by rotation and the reappointment of M/s. M.M. Reddy & Co. as statutory auditors.

Special business approved

A special resolution was passed regarding the reappointment of Mr. Suryaprakasa Rao Bommisetti as an Independent Director. The company disclosed that promoters and promoter group members had an interest in this specific resolution.

Voting participation details

Voting results indicated high promoter participation and moderate public engagement. Promoters voted on 100% of their holding, while non-institutional public shareholders voted on approximately 34.26% of their holding. No votes were cast against any resolution.

Resolution Type Votes Polled Votes in Favour Votes Against Result
Ordinary (Financials) 13,560,514 13,560,514 0 Passed
Ordinary (Director Reappt.) 13,560,514 13,560,514 0 Passed
Special (Ind. Dir. Reappt.) 13,560,514 13,560,514 0 Passed

What the Numbers Show

The voting data reveals a significant divergence in shareholder engagement between promoter groups and public investors. While promoters cast votes on 100% of their 11,262,084 shares, non-institutional public shareholders participated on only 2,298,430 out of 6,709,239 shares held. This results in a public participation rate of roughly 34%, compared to full participation from the promoter group, highlighting a concentration of voting power among insiders.

Historical Stock Returns for Bandaram Pharma Packtech

1 Day5 Days1 Month6 Months1 Year5 Years
+1.69%-1.40%+10.94%-25.52%-33.43%-10.25%

How might the 34% public shareholder participation rate impact Bandaram Pharma Packtech's future corporate governance ratings and institutional investor confidence?

What specific strategic initiatives or capital expenditure plans were outlined in the FY26 financial statements that could drive growth in the upcoming fiscal year?

Given the unanimous approval and lack of dissenting votes, how will the company address potential regulatory scrutiny regarding the concentration of voting power among promoters?

Bandaram Pharma Packtech
View Company Insights
View All News
like15
dislike

More News on Bandaram Pharma Packtech

1 Year Returns:-33.43%